Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Cellceutix Corporation Selects Destum Partners To Partner Psoriasis Compound
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2251884" data-attributes="member: 124445"><p>Cellceutix Corporation (OTCBB: CTIX) is pleased to announce that it has selected Destum Partners to assist in finding a development partner for its psoriasis compound, KM-133. Cellceutix management has carefully evaluated which direction to take in the development of KM-133 and has concluded that this is the best way to create shareholder value. In a human xenograft animal model of psoriasis, KM-133 reduced psoriasis significantly more than controls...<a href="http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/sHjZTrfFpSs" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/sHjZTrfFpSs/3GzR" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2251884, member: 124445"] Cellceutix Corporation (OTCBB: CTIX) is pleased to announce that it has selected Destum Partners to assist in finding a development partner for its psoriasis compound, KM-133. Cellceutix management has carefully evaluated which direction to take in the development of KM-133 and has concluded that this is the best way to create shareholder value. In a human xenograft animal model of psoriasis, KM-133 reduced psoriasis significantly more than controls...[URL="http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/0/da"][IMG]http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/1/da"][IMG]http://feedads.g.doubleclick.net/~a/JD66DMXSPxFE-dg91dOG69V-JKA/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/sHjZTrfFpSs[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/sHjZTrfFpSs/3GzR]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top